Yurpeak (tirzepatide): uses, dosage, side effects and price in India

Dr Nisha Dahiya
Medically reviewed by Dr Nisha Dahiya · Written by PharmEasy Medical Team · Published on 21 August 2026 | Updated on 21 August 2026

Yurpeak is a brand of tirzepatide that was launched on 10 December 2025. It contains the same active ingredient as Mounjaro.

Yurpeak is manufactured by Eli Lilly and distributed in India by Cipla. It is a once-weekly injection approved in India for the management of type 2 diabetes and chronic weight management. It is a Schedule H prescription medicine and can only be purchased with a valid doctor’s prescription.1,3

It is very important to understand that Yurpeak is neither a new medicine nor a generic version of Mounjaro. It contains the same active ingredient (tirzepatide) and also has the same approved indications in India. The only difference is that while Eli Lilly manufactures both medicines, Cipla is responsible for the distribution of Yurpeak across India. This is aimed at helping improve access through its established distribution network.

Prescription required. Yurpeak is a Schedule H medicine. It requires a doctor’s prescription. Our pharmacist verifies every order before it is dispatched.

Quick facts

Active molecule
Tirzepatide (the same as Mounjaro)
Drug class
Dual GIP and GLP-1 receptor agonist
Made by
Eli Lilly
Distributed in India by
Cipla
Form
Once-weekly injection (KwikPen prefilled pen)
Strengths in India
2.5, 5, 7.5, 10, 12.5, 15 mg
Approved in India for
Type 2 diabetes and chronic weight management
Launched in India
10 December 2025
Prescription status
Schedule H (prescription needed)
Price
5 mg KwikPen at ₹16,406 MRP

Is Yurpeak the same as Mounjaro?

This is one of the most common questions people have: are Yurpeak and Mounjaro the same? The short answer is yes, they are similar. They contain the same active ingredient, tirzepatide.3 So, both of them work in the same way and are approved in India for the same indications. Both are also manufactured by Eli Lilly. The only differences are the branding and distribution (not the medicine itself), as they are distributed by different brands.

Points to note:
Same active ingredient. Both Yurpeak and Mounjaro contain tirzepatide and are manufactured by Eli Lilly.3
Both have different distribution networks. Yurpeak is distributed through Cipla’s network, which may help improve availability in different parts of the country.3
Similar pricing. Yurpeak is positioned at a price comparable to Mounjaro for equivalent strengths rather than as a lower-cost generic.5

If your doctor has prescribed tirzepatide, Yurpeak and Mounjaro are clinically equivalent brands containing the same active ingredient. However, you should only switch between brands after discussing it with your doctor. You can also compare the two in our Yurpeak vs Mounjaro guide or learn more on the Mounjaro hub.

Important: Yurpeak is not the same as semaglutide. Semaglutide (available in brands such as Ozempic, Wegovy, and Rybelsus) is a different medicine that activates only one receptor, whereas tirzepatide activates two receptors. Although both medicines belong to the incretin class, they have different dosing schedules, approved indications, and clinical profiles.

How Yurpeak works

Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It is often referred to as a ‘twincretin’ because it works by activating two naturally occurring gut hormone receptors that help regulate blood sugar and appetite.3,4

GLP-1: This receptor is also targeted by semaglutide. Activation of the GLP-1 receptor stimulates insulin release when blood glucose levels are high, reduces glucagon secretion, slows stomach emptying, and helps reduce appetite.
GIP: GIP is another naturally occurring gut hormone (targeted only by tirzepatide). Activating its receptor also supports insulin release and may further contribute to appetite regulation and metabolic effects.

Therefore, by activating both the GIP and GLP-1 receptors, tirzepatide differs from medicines such as semaglutide, which target only the GLP-1 receptor. This dual action helps improve blood glucose control in people with type 2 diabetes and supports chronic weight management when used alongside a reduced-calorie diet and increased physical activity.

What Yurpeak is approved for in India

Yurpeak is approved in India for two indications:1,3

Type 2 diabetes: to improve blood glucose control in adults, alongside diet and exercise.
Chronic weight management: for adults living with obesity, or overweight with at least one weight-related health condition (as part of a reduced-calorie diet and increased physical activity).

In December 2025, the World Health Organization (WHO) published its first global guideline recognising obesity as a chronic disease and recommending GLP-1 receptor agonists for eligible adults living with obesity.2

Note: For chronic weight management, this medicine is generally considered for adults with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea.7 However, your doctor will determine whether Yurpeak is appropriate based on your individual health needs.

Important: Yurpeak is intended to be used alongside healthy lifestyle changes, including a balanced diet and regular physical activity. It is designed for long-term treatment under medical supervision rather than as a quick fix.

Yurpeak strengths and prices

Yurpeak is available as a once-weekly KwikPen, which is a prefilled pen, in six strengths. The prices below are the maximum retail prices (MRPs) listed as of August 2026. Prices may change over time, so always check the latest price before purchasing. PharmEasy’s selling price is often lower than MRP.

Strength3 Pack / form MRP (₹)5 Order (prescription required)
Yurpeak 2.5 mgKwikPen prefilled pen₹13,125View 2.5 mg pen
Yurpeak 5 mgKwikPen prefilled pen₹16,406View 5 mg pen
Yurpeak 7.5 mgKwikPen prefilled pen₹20,625View 7.5 mg pen
Yurpeak 10 mgKwikPen prefilled pen₹20,625View 10 mg pen
Yurpeak 12.5 mgKwikPen prefilled pen₹25,781View 12.5 mg pen
Yurpeak 15 mgKwikPen prefilled pen₹25,781View 15 mg pen
The 2.5 mg pen is the starting dose3 and is intended to help your body adjust to the medicine. It is not the usual maintenance dose, so your long-term treatment cost will depend on the maintenance strength your doctor prescribes. For a detailed comparison of prices by strength, see our Yurpeak price page.

PharmEasy dispenses only 100% genuine, cold-chain-shipped medicines from licensed pharmacies. Since counterfeit GLP-1 related products have been reported in India (2026), it is very important to buy these medications only against a prescription from a licensed pharmacy.

Prices change with strength and pack. See the full ladder, or work out what your prescribed dose would cost each month. Cost calculator

Yurpeak dosage and titration

Yurpeak is given as a once-weekly injection under the skin (subcutaneous injection). Choose the same day each week for your injection. It can be taken with or without food. Rotate the injection site each week between the abdomen, thigh, or upper arm.3

Treatment begins with a low dose that is increased gradually to help your body adjust to the medicine:3

Starting dose

It usually starts with 2.5 mg once weekly. This is the starting dose and is intended to help your body adjust to the medicine. It is not the usual maintenance dose.

Dose escalation

Your doctor will gradually increase the dose, typically every four weeks, if needed and well tolerated.

Maintenance dose

The maintenance dose is selected from the 5 mg to 15 mg range based on your response to treatment and how well you tolerate the medicine. Never change or increase the dose on your own. This should strictly be done only under medical supervision.

Note: If you miss a dose of Yurpeak, you may still be able to take it within a certain time period and then continue with your usual weekly schedule. If too much time has passed, you should skip the missed dose and take your next dose on your regularly scheduled day. Always follow your doctor’s, pharmacist’s, or the patient information leaflet’s instructions if you miss a dose.

Yurpeak side effects

Like all medicines, Yurpeak can cause side effects, although not everyone may experience them. Most side effects affect the digestive system and are more common when treatment begins or when the dose is increased. It often improves as your body adjusts to the medicine.

Most common side effects (often ease with time)
Nausea
Diarrhoea
Constipation
Vomiting
Reduced appetite
Indigestion
Bloating
Burping
Less common side effects
Injection-site reactions, such as redness or itching
Low blood sugar (hypoglycaemia), particularly when Yurpeak is used together with insulin or a sulfonylurea
Dizziness
Tiredness
Hair thinning
Serious but rare side effects (get medical help if they occur)
Inflammation of the pancreas (pancreatitis)
Gallbladder problems (such as gallstones)
Kidney problems, often linked to dehydration from severe vomiting or diarrhoea
Serious allergic reactions

Note: Eating smaller, plain meals, avoiding heavy or fatty foods, and staying well hydrated may help reduce these symptoms while your body adjusts to the medicine.

When to stop and call your doctor.

Seek medical help right away if you have severe or persistent stomach pain (a sign of possible pancreatitis), signs of an allergic reaction, or symptoms of very low blood sugar (shakiness, sweating, confusion).

For more tips on managing the common gut-related side effects, see our GLP-1 side-effects guide.

Who should not take Yurpeak?

Yurpeak is generally not suitable for everyone. Therefore, before you start treatment, tell your doctor about your complete medical history and any medicines you are taking.

Yurpeak should not be used if you:3

×Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
×Have had a serious allergic reaction to tirzepatide or any of the other ingredients in Yurpeak.

Tell your doctor before taking Yurpeak if you:3

×Have type 1 diabetes or diabetic ketoacidosis (DKA), as Yurpeak is not indicated for these conditions.
×Have a history of pancreatitis or severe gastrointestinal disease.
×Are pregnant, planning to become pregnant, or breastfeeding.
×Take oral medicines like oral contraceptive pills, as tirzepatide may reduce their absorption.

Important: Always tell your doctor about all the medicines you take, including prescription medicines, over-the-counter medicines, and supplements, as well as any existing medical conditions before starting Yurpeak.

How to get Yurpeak in India legally

Yurpeak is a Schedule H prescription medicine and cannot be purchased over the counter. A valid doctor’s prescription is required before it can be shipped by any pharmacy. To get a genuine product, follow these steps:1,3,6

1
Consult a doctor.

Your doctor will determine whether Yurpeak is appropriate for you and prescribe it if suitable. From March 2026, India’s drug regulator advised that GLP-1 medicines should be prescribed by specialists like endocrinologists, internal-medicine physicians and cardiologists.

2
Buy from a licensed pharmacy.

Upload your prescription when ordering. At PharmEasy, your prescription will be verified before the medicine is dispatched. We store and transport according to the manufacturer’s recommended temperature requirements (in cold chain packaging).

3
Avoid unverified sellers.

Buy Yurpeak only from licensed pharmacies using a valid prescription to reduce the risk of counterfeit or improperly stored medicines. PharmEasy dispenses only 100% genuine, cold-chain-shipped medicines from licensed pharmacies.

You should be careful while purchasing a GLP-1 pen. It is particularly important because counterfeit Mounjaro pens were seized in Gurugram in April 20268. So, if you receive a Yurpeak pen, check that the brand name, strength, batch number, expiry date, and packaging are correct before use. If you have concerns about the product’s authenticity or storage conditions, contact the pharmacy before using it.

If you already have a prescription, you can view Yurpeak on PharmEasy.

Consult a doctor
Not sure whether you would meet the criteria a doctor looks at? The self-check walks through them in about a minute. Am I eligible?

Storing Yurpeak in Indian conditions

Yurpeak is a biologic medicine that is sensitive to heat, so it should be stored correctly (especially in summer) to maintain its effectiveness.3 Follow these steps for safe storage:

Before first use
Store in the refrigerator. Keep the pen refrigerated at 2°C to 8°C until it is ready to use. Do not store it in the freezer or next to the freezer compartment.
Do not freeze. If the pen has been frozen, do not use it.
Protect it from heat and light. Keep the pen in its original carton and away from direct sunlight and excessive heat (like gas stoves).
After first use
Follow the in-use storage instructions. Yurpeak may be stored under specified conditions for a limited period. So, always follow the storage instructions provided in the patient information leaflet.
General storage tips
Take care during travel. If you need to carry the pen for an extended period, use an insulated bag with a cool pack. Avoid placing the pen in direct contact with the ice pack, and refrigerate it again as soon as possible.

When you order from PharmEasy, Yurpeak is shipped in a cold chain. This ensures that it reaches you at the right temperature.

Yurpeak vs Mounjaro

Since Yurpeak and Mounjaro both contain tirzepatide, they work in the same way. So, the main differences are the brand name and how they are distributed in India.

Feature Yurpeak Mounjaro
MoleculeTirzepatideTirzepatide
Made byEli LillyEli Lilly
Distributed in India byCiplaEli Lilly
Approved in India forType 2 diabetes + chronic weight managementType 2 diabetes + chronic weight management
FormOnce-weekly KwikPen injectionOnce-weekly vial or KwikPen injection
5 mg KwikPen MRP₹16,406₹16,406
Distribution reachWider (Cipla network, includes tier 2 and 3 cities)Eli Lilly network

Both brands contain the same active ingredient (tirzepatide) and are therefore similarly priced for equivalent strengths. So, the choice of which one to choose often depends on availability and your doctor’s recommendation. Compare prices on the Mounjaro price page and learn more on the Mounjaro hub.

Compare Yurpeak directly against the other GLP-1 medicines available in India. Compare all brands

Frequently asked questions

What is Yurpeak?

Yurpeak is a brand of tirzepatide, which is a once-weekly injectable dual GIP and GLP-1 receptor agonist. It is manufactured by Eli Lilly and distributed in India by Cipla. Yurpeak was launched in India on 10 December 2025 and is approved for the management of type 2 diabetes and chronic weight management.1,3

Is Yurpeak the same as Mounjaro?

Yurpeak and Mounjaro both contain the same active ingredient (tirzepatide) and are manufactured by Eli Lilly. The main differences are the brand name and distribution in India. Yurpeak is distributed by Cipla and Mounjaro is distributed by Eli Lilly itself at a similar price range. Your doctor will advise which brand is appropriate for you. You should never switch between brands without medical advice.3,4

Is Yurpeak a semaglutide or a generic Ozempic?

No, Yurpeak contains tirzepatide, whereas Ozempic, Wegovy, and Rybelsus contain semaglutide. Tirzepatide activates both the GIP and GLP-1 receptors, while semaglutide activates only the GLP-1 receptor. Also, keep in mind that Yurpeak is not a generic version of Ozempic.

What is the price of Yurpeak in India?

As of August 2026, the Yurpeak 5 mg KwikPen has an MRP of ₹16,406. However, prices may vary by strength and might also change over time. So, always check the latest price before purchasing. Check our Yurpeak Price in India guide for a detailed price comparison.6

What strengths does Yurpeak come in?

Yurpeak is available as a KwikPen prefilled pen in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The treatment plan usually begins with 2.5 mg once weekly to help your body adjust to the medicine before your doctor increases the dose (if needed) to a maintenance dose.3

Do I need a prescription for Yurpeak?

Yurpeak is a Schedule H prescription medicine and cannot be purchased over the counter. A valid doctor’s prescription is required before it can be shipped from any pharmacy.1,3

Is Yurpeak approved for weight loss in India?

Yurpeak is approved in India for chronic weight management as well as type 2 diabetes. It is meant to be used alongside a reduced-calorie diet and increased physical activity in eligible adults and under medical supervision.1,3

How should I store Yurpeak?

Store Yurpeak in the refrigerator at 2°C to 8°C, in its original carton, protected from heat and light. Do not freeze it. And after using it once, follow the storage instructions in the patient information leaflet for the recommended storage temperature and maximum in-use period. PharmEasy ships it cold-chain.3

References

1.CDSCO (Central Drugs Standard Control Organisation). Indian drug approval records. Available from: https://www.cdscoonline.gov.in/CDSCO/cdscoDrugs/
2.World Health Organization. First global guideline on GLP-1 therapies for adults with obesity (1 December 2025). Available from: https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
3.Eli Lilly / Cipla. Tirzepatide (Yurpeak) prescribing information. Available from: https://www.ciplamed.com/product-index/yurpeak-kwikpen/
4.NEJM - SURMOUNT-1 and SURMOUNT-5 tirzepatide trials. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
5.PharmEasy. Tirzepatide - Uses, Side Effects, Medicines & FAQs [Internet]. Mumbai: PharmEasy; 2026 [cited 2026 Jul 27]. Available from: https://pharmeasy.in/molecules/tirzepatide-4386906
6.Press Information Bureau / DCGI advisory on GLP-1 prescribing and counterfeit seizures (2026). Available from: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2247459®=3&lang=1
7.Jensterle M, Rizzo M, Haluzík M, Janež A. Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review. Adv Ther. 2022 Jun;39(6):2452-2467. doi: 10.1007/s12325-022-02153-x. Epub 2022 May 3. PMID: 35503498; PMCID: PMC9063254. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9063254/
8.India Today Video Desk. Fake Mounjaro racket busted in Gurugram: Is your Mounjaro real? Here’s how to check [Internet]. India Today; 2026 Apr 21 [cited 2026 Jul 28]. Available from: https://www.indiatoday.in/health/video/fake-mounjaro-racket-busted-in-gurugram-is-your-mounjaro-real-heres-how-to-check-2899187-2026-04-21
Disclaimer

The information provided in this GLP-1 Library is intended solely to educate and inform users about GLP-1 medicines, their uses, benefits, risks, and other relevant considerations. The purpose of this content is to help users make informed decisions and have meaningful discussions with their healthcare professional. PharmEasy does not intend to promote or recommend any specific medicine, brand or treatment.

The information provided is for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment, and should not be considered a substitute for consultation with a qualified doctor or other healthcare professional. Before starting, stopping, or changing any medication or treatment, please consult your doctor or qualified healthcare professional. Your doctor can assess your individual health needs and determine whether a GLP-1 medicine is appropriate for you.